- Home
- SPCE vs HUMA Comparison
SPCE vs HUMA Comparison
Compare SPCE & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | HUMA |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.3M | 182.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SPCE | HUMA |
|---|---|---|
| Price | $3.17 | $1.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $9.22 | ★ $10.13 |
| AVG Volume (30 Days) | ★ 6.2M | 5.3M |
| Earning Date | 02-25-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,661,000.00 | $1,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,656.89 | $698.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $0.91 |
| 52 Week High | $6.64 | $5.33 |
Technical Indicators
Market Signals| Indicator | SPCE | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 50.88 |
| Support Level | $3.15 | $0.91 |
| Resistance Level | $3.37 | $1.25 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 4.66 | 75.00 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.